Our Solutions

Accelerate Approval & Launch Readiness.

Shorten time to approval and move forward with the confidence that your non-clinical safety, regulatory and clinical strategies, CMC development, and supply-chain are compliant and aligned end-to-end.

The pre-approval phase is where the foundation of a product’s entire lifecycle is built. Decisions made early — on development strategy, regulatory pathway, CMC approach, non-clinical programme design and supply chain — shape everything that follows: timelines, costs, approval probability and long-term market viability.

PLG’s team brings together experts across regulatory affairs, clinical development, non-clinical sciences, CMC and quality to support life sciences companies at every stage of development — from early candidate selection through to submission readiness and first approval. Our integrated approach means your scientific, regulatory and operational strategies are designed to work together, not in silos.

Whether you are advancing a novel biopharmaceutical, a medical device or a consumer health product, PLG provides the expertise, the global regulatory intelligence and the strategic oversight to help you move faster — and with greater confidence — towards the approval that matters.

PLG’s Engineering Centre of Excellence 

GxP design and construction services for life sciences 

Building a pharmaceutical or biotech facility is both a major commercial decision and a regulatory commitment. Every design choice, system specification and qualification protocol can directly affect GMP compliance, inspection readiness and eventual market supply. 

PLG’s Engineering Centre of Excellence has delivered expert life sciences design and construction projects for over 20 years, spanning feasibility studies, detailed engineering, EPC/EPCM delivery and ongoing site maintenance.

Through our Define. Design. Deliver. methodology, we tailor each specific project and embed compliance across every design stage through to final delivery. 

Whether you are launching a greenfield build, expanding existing capacity or qualifying a site for a new product line, we ensure the technical rigour and regulatory insight required for immediate production, seamless inspection and future commercial growth.

Prove Value & Secure Access.

We accelerate and optimize access to therapeutic innovation by combining global reach with deep local expertise, seamlessly integrating Market and Patient Access with cross-functional capabilities to support life sciences companies in navigating complexity, shaping policy, and delivering sustainable value to healthcare systems and patients.

A successful regulatory approval is a critical milestone, but it does not guarantee patient access to your product. In today’s environment, developing a comprehensive market access strategy is as demanding as the approval process itself. Payers, health technology assessment (HTA) bodies, and healthcare systems require robust evidence of clinical and economic value before granting reimbursement. Successful pricing and reimbursement strategies demand early planning, deep local knowledge, and the ability to operate across regulatory, scientific, commercial, and policy dimensions simultaneously. 

PLG’s team supports life sciences companies through every dimension of market and patient access, from early engagement and pricing strategy through health economics, HTA submissions, reimbursement negotiations, public affairs, and patient access programmes.

With a presence across more than 30 countries in Europe and a global network spanning North America, Asia-Pacific, and beyond, we combine the strategic breadth of a global consultancy with the local intelligence that makes the difference in individual markets. 

Our services — Market Access and Pricing Strategy, HTA and Pricing & Reimbursement, Health Economics and Modeling, Value Evidence and Medical Strategy and Policy and Advocacy — are designed to work as an integrated offer or to complement your existing capabilities where specialist support is needed most. 

Stay Compliant, Ready, and Safe.

Ensuring access to products and patient safety across the lifecycle.

Receiving regulatory approval is a defining milestone — but it marks the beginning of a new set of obligations, not the end of the journey. Once a product is on the market, maintaining compliance, managing safety data, responding to regulatory changes and protecting supply continuity become ongoing priorities that require dedicated expertise and constant vigilance.

The post-approval landscape is increasingly complex. Regulatory authorities across global markets continue to raise the bar on pharmacovigilance, quality standards and lifecycle management requirements. A product change, a safety signal, a manufacturing variation or a new market expansion can each trigger a cascade of regulatory activity that demands a coordinated, experienced response.

PLG’s team provides end-to-end support across the four critical pillars of lifecycle management: Life Cycle management, Regulatory Solutions, Quality & Compliance, and Manufacturing & Supply Chain. Our experts work alongside your teams to anticipate regulatory requirements, manage change efficiently and ensure your product remains safe, compliant and accessible to patients — in every market where it is authorised.

Complete, compliant, and innovative digital solutions to life sciences challenges.

While AI and digital developments promise to revolutionise the life sciences sector, practical application is often hindered by disconnected software systems, isolated data architectures, and stringent regulatory demands such as GxP frameworks and the European AI Act.  

Many technology vendors lack the necessary industry and compliance experience, whilst standard consultancies often lack technical engineering depth. ProductLife Group (PLG) bridges this gap by combining engineering proficiency with comprehensive regulatory and sector knowledge. We deploy operational, fully compliant digital solutions that turn technological potential into measurable corporate value.  

Our Strategic Consulting service provides comprehensive market analyses on technological potential and market success, identifying exactly where digital intervention will unlock the highest value and growth by maximising operational efficiency. 

PLG also operates as an unbiased, vendor-neutral consultant across both early-stage and commercialised operations. Our early-stage pre-approval services systematically reduce risks within research and development pipelines by guiding application selection and mapping out digital deployment strategies.  

And once a product is approved, our post-marketing services optimise ongoing operations from a digital/AI centric approach across manufacturing, pharmacovigilance, laboratories, and global supply chains.  

Our Digital Innovation Centre of Excellence in Paris uses proprietary computing infrastructure built on NVIDIA Grace Blackwell technology. Alongside the processing power this provides it enables us to process sensitive client information locally, avoiding the security vulnerabilities and latency issues associated with standard cloud infrastructure.  

DAIMI, our modular AI ecosystem, allows life sciences teams to coordinate complex workflows across multiple systems with full operational traceability. Furthermore, DAIMI is being built from the ground up to take advantage of AI to orchestrate these outcomes by simply using natural language commands.  

For businesses managing complex data integrations during corporate acquisitions or upgrades, our nine-stage migration framework together with our digital tools now indexes, cleans, and validates legacy information into compliant target repositories.  

Our Digital Quality team are now combining 30+ years of global validation expertise with the ValKit.ai platform to reduce administrative burdens by up to 50%, allowing teams to focus on safety and data integrity.  

The PLG Digital Innovation team is building a dream AI/digital toolset for life science professionals to eliminate the manual drudgery and potential for errors, so they can focus on bringing greater human expertise to daily processes. 

PLG is replacing manual processes with GxP validated and scalable digital solutions that help industry experts make faster, better, and safer decisions.